Search results
1,533 Shares in AbbVie Inc. (NYSE:ABBV) Acquired by Warren Street Wealth Advisors LLC
ETF DAILY NEWS· 2 days agoWarren Street Wealth Advisors LLC acquired a new position in AbbVie Inc. (NYSE:ABBV – Free Report) in the fourth quarter, according to its most recent 13F filing with the ...
AbbVie and FutureGen Announce License Agreement to Develop Next-Generation Therapy for Inflammatory...
The Port Lavaca Wave· 6 days ago- Global license agreement to focus on the development of FG-M701, a TL1A antibody, for the treatment of inflammatory bowel disease (IBD)
AbbVie's (ABBV) Skyrizi Gets FDA Nod for Ulcerative Colitis
Zacks· 18 hours agoFree Report) announced that the FDA has granted approval to its blockbuster drug, Skyrizi to treat adults with moderately to severely active ulcerative colitis (UC) in the United States. Skyrizi ...
AbbVie (ABBV) Exceeds Market Returns: Some Facts to Consider
Zacks· 2 days agoFree Report) ending at $171.36, denoting a +0.99% adjustment from its last day's close. This change outpaced the S&P 500's 0.25% gain on the day. In that same time, the Medical sector gained ...
AbbVie inks immune disorder drug licensing deal with China's FutureGen
AOL· 6 days agoAbbVie has been counting on its newer immunology medicines to help make up for declining sales of blockbuster arthritis drug Humira following the entry of biosimilars in the ...
Why AbbVie (ABBV) is a Great Dividend Stock Right Now
Zacks· 18 hours agoCash flow can come from bond interest, interest from other types of investments, and of course, dividends. A dividend is the distribution of a company's earnings paid out to shareholders; it's ...
Optimist Retirement Group LLC Purchases New Shares in AbbVie Inc. (NYSE:ABBV)
ETF DAILY NEWS· 6 days agoOptimist Retirement Group LLC acquired a new stake in AbbVie Inc. (NYSE:ABBV – Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities ...
In a 'gold rush' for treating bowel disease, AbbVie clears one more stage
Crain s Chicago Business· 4 hours agoWith the nod from the FDA, Skyrizi joins Rinvoq as immunology drugs in the AbbVie pipeline approved for both IBD conditions, UC and Crohn's. With the arrival of biosimilar ...
B. Riley Wealth Advisors Inc. Sells 15,193 Shares of AbbVie Inc. (NYSE:ABBV)
ETF DAILY NEWS· 2 days agoB. Riley Wealth Advisors Inc. trimmed its holdings in shares of AbbVie Inc. (NYSE:ABBV – Free Report) by 10.4% during the fourth quarter, Holdings Channel.com reports. The ...
Sanibel Captiva Trust Company Inc. Invests $41.99 Million in AbbVie Inc. (NYSE:ABBV)
ETF DAILY NEWS· 5 days agoSanibel Captiva Trust Company Inc. acquired a new position in AbbVie Inc. (NYSE:ABBV – Free Report) in the fourth quarter, according to the company in its most recent disclosure ...
